Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study of A01016 125μg Intravitreal Injection in Subjects With Symptomatic Vitreomacular Adhesion - Comparison Study to Sham Injection

NCT01889251 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT01889251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01889251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study of A01016 125μg Intravitreal Injection in Subjects With Symptomatic Vitreomacular Adhesion - Comparison Study to Sham Injection
Lead sponsor
Alcon Research
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2013
Completion date
September 30, 2014
Enrollment
251 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic vitreomacular adhesion